Chrysanthos Grigoratos
Chrysanthos Grigoratos has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Alberto Balbarini
Angiology Division, Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy
3 shared publicationsFrancesco De Sanctis
Angiology Division, Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy
2 shared publications- Matteo Dell’omodarme
Dipartimento di Fisica “Enrico Fermi”, Università di Pisa
2 shared publications Paolo Spontoni
Angiology Division, Cardiothoracic and Vascular Department, University of Pisa, Pisa, Italy
2 shared publicationsAnca Irina Corciu
1 shared publication- Antonio Giuseppe Naccarato
University of Pisa
1 shared publication
Latest Publications
- Open Access
- 1 December 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 19 (1) , 97
‘Image-navigated 3-dimensional late gadolinium enhancement cardiovascular magnetic resonance imaging: feasibility and initial clinical results‘
- 1 December 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 19 (1) , 97
Open Access‘Image-navigated 3-dimensional late gadolinium enhancement cardiovascular magnetic resonance imaging: feasibility and initial clinical results‘
- 8 July 2014
- Published by SAGE Publications in Angiology
- Vol. 66 (6) , 531-538
Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost
We evaluated the effectiveness of intravenous iloprost (IVI) in outpatients with thromboangiitis obliterans (TAO) and lower limb noninvasive transcutaneous monitoring (TCM) at follow-up (FU). Ten consecutive patients with TAO underwent IVI therapy. Transcutaneous oxygen (TcPo 2 ) and carbon dioxide (TcPco 2 ) determination and laser Doppler flowmetry (LDF) were performed before and after IVI at 3, 6, and 12 months of FU. Clinical response was positive in 7 patients, whereas 3 nonresponders underwent a second IVI cycle with 1 showing a late positive clinical response. After 12 months of FU, all patients were alive without amputations. Supine and dependent TcP 2 levels significantly improved ( P < .005). Hallux LDF values showed significant change with the maximal hyperemic test at 44°C ( P < .005). Forefoot maximal hyperemic test at 44°C LDF ( P < .005) and improved venous arterial reflex ( P < .05) showed statistically significant time evolution. We demonstrated some degree of IVI effectiveness and evaluated TCM in patients with TAO.
- 8 July 2014
- Published by SAGE Publications in Angiology
- Vol. 66 (6) , 531-538
Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost
We evaluated the effectiveness of intravenous iloprost (IVI) in outpatients with thromboangiitis obliterans (TAO) and lower limb noninvasive transcutaneous monitoring (TCM) at follow-up (FU). Ten consecutive patients with TAO underwent IVI therapy. Transcutaneous oxygen (TcPo 2 ) and carbon dioxide (TcPco 2 ) determination and laser Doppler flowmetry (LDF) were performed before and after IVI at 3, 6, and 12 months of FU. Clinical response was positive in 7 patients, whereas 3 nonresponders underwent a second IVI cycle with 1 showing a late positive clinical response. After 12 months of FU, all patients were alive without amputations. Supine and dependent TcP 2 levels significantly improved ( P < .005). Hallux LDF values showed significant change with the maximal hyperemic test at 44°C ( P < .005). Forefoot maximal hyperemic test at 44°C LDF ( P < .005) and improved venous arterial reflex ( P < .05) showed statistically significant time evolution. We demonstrated some degree of IVI effectiveness and evaluated TCM in patients with TAO.